Zydus receives final approval from USFDA for Baclofen Tablets

Zydus Cadila
Sharing is Caring !!

Zydus receives final approval from USFDA for Baclofen Tablets
Ahmedabad, April 18, 2020

Zydus Cadila has received final approval from the USFDA to market Baclofen Tablets, 5 mg. Baclofen is used to treat muscle spasms caused by certain conditions such as multiple sclerosis, spinal cord injury/disease. It works by helping to relax the muscles. It will be manufactured at the group’s formulations manufacturing facility at Baddi. The group now has 288 approvals and has so far filed over 386 ANDAs since the commencement of the filing process in FY 2003-04.
About Zydus Cadila
Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The group employs nearly 25000 people worldwide and is dedicated to creating healthier communities globally. Zydus aspires to be a research-based pharmaceutical company by 2020.

Sharing is Caring !!

Leave a Reply

Your email address will not be published. Required fields are marked *

नेपाल फार्मेसी परिषदको फार्मेसी जनशक्तिमा अपिल
Cresta Posts Box by CP